USNA vs. HLF, NUS, NATR, MED, VERU, EL, IPAR, PBH, TLRY, and CRON
Should you be buying USANA Health Sciences stock or one of its competitors? The main competitors of USANA Health Sciences include Herbalife (HLF), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Tilray (TLRY), and Cronos Group (CRON).
USANA Health Sciences (NYSE:USNA) and Herbalife (NYSE:HLF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, community ranking, institutional ownership, analyst recommendations, dividends and risk.
USANA Health Sciences has a net margin of 6.29% compared to Herbalife's net margin of 2.70%. USANA Health Sciences' return on equity of 11.13% beat Herbalife's return on equity.
In the previous week, USANA Health Sciences had 26 more articles in the media than Herbalife. MarketBeat recorded 31 mentions for USANA Health Sciences and 5 mentions for Herbalife. Herbalife's average media sentiment score of 0.66 beat USANA Health Sciences' score of -0.17 indicating that Herbalife is being referred to more favorably in the news media.
Herbalife has higher revenue and earnings than USANA Health Sciences. Herbalife is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.
Herbalife received 312 more outperform votes than USANA Health Sciences when rated by MarketBeat users. Likewise, 67.49% of users gave Herbalife an outperform vote while only 60.64% of users gave USANA Health Sciences an outperform vote.
USANA Health Sciences presently has a consensus target price of $38.00, suggesting a potential downside of 10.84%. Herbalife has a consensus target price of $10.70, suggesting a potential downside of 14.40%. Given USANA Health Sciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe USANA Health Sciences is more favorable than Herbalife.
USANA Health Sciences has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, Herbalife has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.
54.3% of USANA Health Sciences shares are held by institutional investors. 0.3% of USANA Health Sciences shares are held by insiders. Comparatively, 0.9% of Herbalife shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
USANA Health Sciences beats Herbalife on 10 of the 17 factors compared between the two stocks.
Get USANA Health Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
USANA Health Sciences Competitors List
Related Companies and Tools
